Showing results (71-80 of 240) with videos related to

Sort By:
Pageof 24
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|August 1, 1987
Primary IgG-lambda immunocytoma of the urinary bladderR De Bruyne, O Peters, A Goossens, et al.
Contact Dermatitis|December 20, 1999
Thoughts on sensitizers in a standard patch test series. The European Society of Contact DermatitisM Bruze, L Condé-Salazar, A Goossens, et al.
Allergy|June 16, 2011
Corticosteroid cross-reactivity: clinical and molecular modelling toolsM Baeck, J A Chemelle, A Goossens, et al.
Chest|August 1, 1993
The association of bronchiolitis obliterans organizing pneumonia, systemic lupus erythematosus, and Hunner's cystitisF Mana, T Mets, W Vincken, et al.
Contact Dermatitis|September 30, 2005
The relation between the localization of foot dermatitis and the causative allergens in shoes: a 13-year retrospective studyA Nardelli, M Taveirne, J Drieghe, et al.
Pediatric Hematology and Oncology|January 1, 1991
Retropharyngeal synovial sarcoma in an infant: report of a case and of its response to chemotherapy; review of the literatureP Lenoir, J Ramet, A Goossens, et al.
Molecular and Cellular Biology|September 26, 2000
Regulation of yeast H(+)-ATPase by protein kinases belonging to a family dedicated to activation of plasma membrane transportersA Goossens, N de La Fuente, J Forment, et al.
Free Radical Research Communications|January 1, 1986
Non-enzymic lipid peroxidation in microsomes and microsomal phospholipids induced by anthracyclinesL Sterrenberg, R H Julicher, P A Goossens, et al.
Journal of Infusion Nursing : the Official Publication of the Infusion Nurses Society|February 3, 2005
Central vascular access devices in oncology and hematology considered from a different point of view: how do patients experience their vascular access ports?Godelieve A Goossens, Marc Vrebos, Marguerite Stas, et al.
Journal of Biomolecular Screening|August 7, 2004
High-throughput screening assays for the assessment of CYP2C9*1, CYP2C9*2, and CYP2C9*3 metabolism using fluorogenic Vivid substratesBryan D Marks, David V Thompson, Tony A Goossens, et al.
Pageof 24